vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)

Historical Holders from Q3 2023 to Q3 2025

Symbol
VTVT on Nasdaq
Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
4,080,222
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
988,279
Holdings value
$23,052,921
% of all portfolios
0%
Number of holders
23
Number of buys
11
Number of sells
-4
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Samsara BioCapital, L.P. 9.9% 0% $12,001,117 +$1,803,961 403,942 +18% Srinivas Akkaraju 08 Dec 2025
Invus Global Management, LLC 9.4% -5.9% $9,179,310 +$1,051,154 393,098 +13% Raymond Debbane 30 Sep 2025
Trails Edge Capital Partners, LP 9.9% $5,108,040 340,536 Trails Edge Capital Partners, LP 29 Aug 2025

Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 988,279 $23,052,921 +$9,364,357 $23.35 23
2025 Q2 587,143 $8,742,344 +$226,154 $15 21
2025 Q1 571,712 $9,902,095 +$353,201 $17.32 20
2024 Q4 551,416 $7,570,090 +$133,643 $13.81 17
2024 Q3 542,324 $7,337,088 +$2,516,893 $13.56 20
2024 Q2 348,140 $6,148,038 +$252,272 $17.66 19
2024 Q1 333,650 $7,850,341 +$6,240,904 $23.53 19
2023 Q4 68,620 $788,715 +$781,835 $11.5 14
2023 Q3 600 $287 +$287 $0.4783 1